ALFRED KOOS: Open Payments
NPI 1801265632 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$568 in 29 payments from 6 companies in 2025. Trend: 2023 $336 · 2024 $678 · 2025 $568
Food & beverage: $568
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 11 | $209 |
| GENZYME CORPORATION | 9 | $195 |
| Optinose US, Inc. | 4 | $76 |
| AERIN MEDICAL INC. | 3 | $47 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Stryker Corporation | 1 | $15 |
Products named: DUPIXENT, NUCALA, Xhance, VIVAER STYLUS, AUDION ET DILATION SYSTEM.
Industry payments across AZ — which companies pay providers there.
